R1 RCM Inc. (NASDAQ:RCM) Holdings Increased by Sea Cliff Partners Management LP

Sea Cliff Partners Management LP lifted its stake in R1 RCM Inc. (NASDAQ:RCM) by 14.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,437,450 shares of the healthcare provider’s stock after buying an additional 305,672 shares during the quarter. R1 RCM makes up 10.5% of Sea Cliff Partners Management LP’s holdings, making the stock its 4th largest position. Sea Cliff Partners Management LP owned about 0.58% of R1 RCM worth $30,614,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of RCM. Capital International Investors grew its position in R1 RCM by 0.8% in the fourth quarter. Capital International Investors now owns 8,343,199 shares of the healthcare provider’s stock worth $88,188,000 after acquiring an additional 67,485 shares during the period. Norges Bank acquired a new stake in R1 RCM in the fourth quarter valued at $42,539,000. P2 Capital Partners LLC raised its stake in R1 RCM by 70,366.3% in the fourth quarter. P2 Capital Partners LLC now owns 3,535,294 shares of the healthcare provider’s stock valued at $37,368,000 after buying an additional 3,530,277 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of R1 RCM by 4.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,154,888 shares of the healthcare provider’s stock worth $39,624,000 after purchasing an additional 136,808 shares in the last quarter. Finally, Boston Partners increased its position in shares of R1 RCM by 4,976.6% during the first quarter. Boston Partners now owns 2,570,371 shares of the healthcare provider’s stock worth $32,784,000 after purchasing an additional 2,519,739 shares in the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Trading Up 0.1 %

R1 RCM stock opened at $14.17 on Friday. The stock has a market capitalization of $5.98 billion, a PE ratio of -177.13 and a beta of 0.84. R1 RCM Inc. has a 12-month low of $8.87 and a 12-month high of $15.43. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84. The firm has a 50 day simple moving average of $13.89 and a 200-day simple moving average of $13.02.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The firm had revenue of $627.90 million during the quarter, compared to analysts’ expectations of $633.10 million. The firm’s revenue was up 12.0% compared to the same quarter last year. As a group, equities research analysts expect that R1 RCM Inc. will post -0.24 EPS for the current fiscal year.

Analysts Set New Price Targets

RCM has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft raised their price target on R1 RCM from $14.00 to $16.00 and gave the stock a “hold” rating in a report on Tuesday, July 9th. TD Cowen reissued a “hold” rating and set a $14.30 price target (down previously from $20.00) on shares of R1 RCM in a report on Monday, August 5th. Robert W. Baird reissued an “outperform” rating and set a $18.00 price target on shares of R1 RCM in a report on Tuesday, July 2nd. Cantor Fitzgerald reissued a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a report on Tuesday, August 20th. Finally, Jefferies Financial Group lowered R1 RCM from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Thirteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, R1 RCM presently has an average rating of “Hold” and an average price target of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.